117 related articles for article (PubMed ID: 22569910)
1. Cathepsin K preferentially solubilizes matured bone matrix.
Borel O; Gineyts E; Bertholon C; Garnero P
Calcif Tissue Int; 2012 Jul; 91(1):32-9. PubMed ID: 22569910
[TBL] [Abstract][Full Text] [Related]
2. Contribution of the advanced glycation end product pentosidine and of maturation of type I collagen to compressive biomechanical properties of human lumbar vertebrae.
Viguet-Carrin S; Roux JP; Arlot ME; Merabet Z; Leeming DJ; Byrjalsen I; Delmas PD; Bouxsein ML
Bone; 2006 Nov; 39(5):1073-1079. PubMed ID: 16829221
[TBL] [Abstract][Full Text] [Related]
3. Extracellular post-translational modifications of collagen are major determinants of biomechanical properties of fetal bovine cortical bone.
Garnero P; Borel O; Gineyts E; Duboeuf F; Solberg H; Bouxsein ML; Christiansen C; Delmas PD
Bone; 2006 Mar; 38(3):300-9. PubMed ID: 16271523
[TBL] [Abstract][Full Text] [Related]
4. Changes in skeletal collagen cross-links and matrix hydration in high- and low-turnover chronic kidney disease.
Allen MR; Newman CL; Chen N; Granke M; Nyman JS; Moe SM
Osteoporos Int; 2015 Mar; 26(3):977-85. PubMed ID: 25466530
[TBL] [Abstract][Full Text] [Related]
5. Bisphosphonates alter trabecular bone collagen cross-linking and isomerization in beagle dog vertebra.
Allen MR; Gineyts E; Leeming DJ; Burr DB; Delmas PD
Osteoporos Int; 2008 Mar; 19(3):329-37. PubMed ID: 18094911
[TBL] [Abstract][Full Text] [Related]
6. Decreased beta-isomerization of the C-terminal telopeptide of type I collagen alpha 1 chain in Paget's disease of bone.
Garnero P; Fledelius C; Gineyts E; Serre CM; Vignot E; Delmas PD
J Bone Miner Res; 1997 Sep; 12(9):1407-15. PubMed ID: 9286756
[TBL] [Abstract][Full Text] [Related]
7. Measurement of urinary excretion of nonisomerized and beta-isomerized forms of type I collagen breakdown products to monitor the effects of the bisphosphonate zoledronate in Paget's disease.
Garnero P; Gineyts E; Schaffer AV; Seaman J; Delmas PD
Arthritis Rheum; 1998 Feb; 41(2):354-60. PubMed ID: 9485094
[TBL] [Abstract][Full Text] [Related]
8. Reductions in degree of mineralization and enzymatic collagen cross-links and increases in glycation-induced pentosidine in the femoral neck cortex in cases of femoral neck fracture.
Saito M; Fujii K; Soshi S; Tanaka T
Osteoporos Int; 2006; 17(7):986-95. PubMed ID: 16552468
[TBL] [Abstract][Full Text] [Related]
9. Type I collagen racemization and isomerization and the risk of fracture in postmenopausal women: the OFELY prospective study.
Garnero P; Cloos P; Sornay-Rendu E; Qvist P; Delmas PD
J Bone Miner Res; 2002 May; 17(5):826-33. PubMed ID: 12009013
[TBL] [Abstract][Full Text] [Related]
10. Determination of bone markers in pycnodysostosis: effects of cathepsin K deficiency on bone matrix degradation.
Nishi Y; Atley L; Eyre DE; Edelson JG; Superti-Furga A; Yasuda T; Desnick RJ; Gelb BD
J Bone Miner Res; 1999 Nov; 14(11):1902-8. PubMed ID: 10571690
[TBL] [Abstract][Full Text] [Related]
11. An inhibitor of cathepsin K, icariin suppresses cartilage and bone degradation in mice of collagen-induced arthritis.
Sun P; Liu Y; Deng X; Yu C; Dai N; Yuan X; Chen L; Yu S; Si W; Wang X; Wu D; Liu S; Pang H
Phytomedicine; 2013 Aug; 20(11):975-9. PubMed ID: 23746958
[TBL] [Abstract][Full Text] [Related]
12. The type I collagen fragments ICTP and CTX reveal distinct enzymatic pathways of bone collagen degradation.
Garnero P; Ferreras M; Karsdal MA; Nicamhlaoibh R; Risteli J; Borel O; Qvist P; Delmas PD; Foged NT; Delaissé JM
J Bone Miner Res; 2003 May; 18(5):859-67. PubMed ID: 12733725
[TBL] [Abstract][Full Text] [Related]
13. Non-isomerized C-telopeptide fragments are highly sensitive markers for monitoring disease activity and treatment efficacy in Paget's disease of bone.
Alexandersen P; Peris P; Guañabens N; Byrjalsen I; Alvarez L; Solberg H; Cloos PA
J Bone Miner Res; 2005 Apr; 20(4):588-95. PubMed ID: 15765177
[TBL] [Abstract][Full Text] [Related]
14. Bone turnover and type I collagen C-telopeptide isomerization in adult osteogenesis imperfecta: associations with collagen gene mutations.
Garnero P; Schott AM; Prockop D; Chevrel G
Bone; 2009 Mar; 44(3):461-6. PubMed ID: 19071236
[TBL] [Abstract][Full Text] [Related]
15. Zinc Inhibits Collagenolysis by Cathepsin K and Matrix Metalloproteinases in Demineralized Dentin Matrix.
Altinci P; Seseogullari-Dirihan R; Can G; Pashley D; Tezvergil-Mutluay A
Caries Res; 2017; 51(6):576-581. PubMed ID: 29024928
[TBL] [Abstract][Full Text] [Related]
16. In vitro non-enzymatic ribation reduces post-yield strain accommodation in cortical bone.
Willett TL; Sutty S; Gaspar A; Avery N; Grynpas M
Bone; 2013 Feb; 52(2):611-22. PubMed ID: 23178516
[TBL] [Abstract][Full Text] [Related]
17. An in vitro model to test the contribution of advanced glycation end products to bone biomechanical properties.
Viguet-Carrin S; Farlay D; Bala Y; Munoz F; Bouxsein ML; Delmas PD
Bone; 2008 Jan; 42(1):139-49. PubMed ID: 17974517
[TBL] [Abstract][Full Text] [Related]
18. Characterization of urinary degradation products derived from type I collagen. Identification of a beta-isomerized Asp-Gly sequence within the C-terminal telopeptide (alpha1) region.
Fledelius C; Johnsen AH; Cloos PA; Bonde M; Qvist P
J Biol Chem; 1997 Apr; 272(15):9755-63. PubMed ID: 9092508
[TBL] [Abstract][Full Text] [Related]
19. Immunochemical characterization of assay for carboxyterminal telopeptide of human type I collagen: loss of antigenicity by treatment with cathepsin K.
Sassi ML; Eriksen H; Risteli L; Niemi S; Mansell J; Gowen M; Risteli J
Bone; 2000 Apr; 26(4):367-73. PubMed ID: 10719280
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of cathepsin K reduces bone erosion, cartilage degradation and inflammation evoked by collagen-induced arthritis in mice.
Svelander L; Erlandsson-Harris H; Astner L; Grabowska U; Klareskog L; Lindstrom E; Hewitt E
Eur J Pharmacol; 2009 Jun; 613(1-3):155-62. PubMed ID: 19358841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
